Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1975-02-10
1976-08-24
Gotts, Lewis
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
039767701
ABSTRACT:
A new octapeptide having profound angiotensin antagonist properties has been found. The new compound resembles angiotensin II except for the two terminal amino acids, carrying unnatural amino acids at the N-terminus, and at the C-terminus.
REFERENCES:
patent: 3886134 (1975-05-01), Sipos et al.
Bumpus Francis Merlin
Khosla Mahesh Chandra
Smeby Robert Rudolph
Burgauer Paul D.
Gotts Lewis
Niblack Robert L.
Suyat Reginald J.
LandOfFree
Sar'-(OMe)Thr.sup.8 Angiotensin II as an angiotensin II antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sar'-(OMe)Thr.sup.8 Angiotensin II as an angiotensin II antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sar'-(OMe)Thr.sup.8 Angiotensin II as an angiotensin II antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-779468